MacroGenics | Despesas Operacionais



Operating Expenses Alterar Data
AbbVie USD 16.59B 5.96B 2024-12
Amgen USD 6.78B 401M 2024-12
AstraZeneca USD 12.86B 2.06B 2024-12
Biogen USD 2.01B 13.3M 2024-12
Bristol-Myers Squibb USD 11.55B 1.84B 2024-12
Daiichi Sankyo JPY 423.43B 70.8B 2024-12
Eli Lilly USD 8.38B 1.53B 2024-12
Genmab DKK 4.25B 812M 2024-12
Geron USD 69.29M 12.81M 2024-12
Gilead Sciences USD 5.12B 1.54B 2024-12
J&J USD 8.26B 10.37B 2025-03
MacroGenics USD 35.94M 20.58M 2024-12
Merck USD 11.33B 1.4B 2024-12
Pfizer USD 18.17B 5.63B 2024-12
Regeneron Pharmaceuticals USD 2.8B 26.53B 2024-12
Roche Holding CHF 11.43B 1.48B 2024-12
Xencor USD 65.97M 7.02M 2024-12



MacroGenics Despesas Operacionais - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Apr 2025.